Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

v3.21.2
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
3 Months Ended 4 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2020
Sep. 30, 2021
Cash Flows from Operating Activities:        
Net income (loss)     $ (818,071) $ 17,044,620
Adjustments to reconcile net income (loss) to net cash used in operating activities:        
Change in fair value of derivative warrant liabilities $ (20,336,305)     (21,656,844)
Transaction costs associated with the Initial Public Offering   $ 715,720 715,720  
Interest earned on investments held in Trust Account (18,214) (20,204) (20,204) (82,072)
Changes in operating assets and liabilities:        
Prepaid expenses     (327,842) 100,860
Accrued expenses     57,916 3,058,075
Net cash used in operating activities     (392,481) (1,535,361)
Cash Flows from Investing Activities:        
Investment of cash into Trust Account     (334,215,700)  
Net cash used in investing activities     (334,215,700)  
Cash Flows from Financing Activities:        
Proceeds from issuance of Class B common stock to Sponsor     25,000  
Proceeds from sale of Units, net of underwriting discounts paid     327,531,386  
Proceeds from sale of Private Placement Warrants     9,700,000  
Repayment of promissory note - related party     (52,250)  
Payment of offering costs     (11,300) (17,000)
Net cash (used in) provided by financing activities     337,192,836 (17,000)
Net Change in Cash     2,584,655 (1,552,361)
Cash - Beginning     0 2,245,798
Cash - Ending $ 693,437 $ 2,584,655 2,584,655 $ 693,437
Non-cash investing and financing activities:        
Offering costs included in accrued offering costs     402,480  
Offering costs paid through promissory note     52,250  
Deferred underwriting fee payable     $ 11,697,550